Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...
After weeks of what had been tightly buttoned talks between the parties, Senate Democrats have delivered their latest counteroffer on the crypto market structure bill, outlining a set of demands ...
Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...
Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...
What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...
The White House is facing criticism after citing data from food delivery service DoorDash to claim progress in reducing inflation. The report analyzes hundreds of millions of DoorDash transactions to ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min TierPoint, a St. Louis-based ...
Bloomberg News is tracking the daily gyrations and cumulative impact of Donald Trump’s second term on stocks, the dollar, 10-year Treasury notes, gold and Bitcoin. Click here to see the tracker . Data ...
New data challenge Democrats’ central claim in the ongoing government funding standoff. For nearly three weeks, Democrats have refused to back any funding bill unless it includes an extension of COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results